Effect of long-term administration of an injectable enrofloxacin solution on physical and musculoskeletal variables in adult horses

Journal of the American Veterinary Medical Association

Volumn 217, Issue 10, 2000, Pages 1514-1521

  Bertone, Alicia L ^a   Tremaine, W Henry ^a   Macoris, Delphim G ^a   Simmons, Emily J ^a   Ewert, Kathleen M ^b   Herr, Leslie G ^c   Weisbrode, Steven E ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b BAYER CORPORATION   (United States)

^c Epidemiol Consult Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ARTICLE; ARTICULAR CARTILAGE; BONE BIOPSY; CELLULITIS; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; DRUG SCREENING; HORSE; LONG TERM CARE; NONHUMAN; OSTEOPHYTE; PHYSICAL EXAMINATION; TENDINITIS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0034669653     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2000.217.1514     Document Type: Article

References (42)

1. Neer TM. Clinical pharmacologic features of fluoroquinolone antimicrobial drugs. J Am Vet Med Assoc 1988;193:577-580.
2. Giguere S, Sweeney RW, Belanger M. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. Am J Vet Res 1996;57:1025-1030.
3. Langston VC, Sedrish S, Boothe DM. Disposition of single-dose oral enrofloxacin in the horse. J Vet Pharmacol Ther 1996;19: 316-319.
4. Kaartinen L, Panu S, Pyorala S. Pharmacokinetics of enrofloxacin in horses after single and intravenous and intramuscular administration. Equine Vet J 1997;29:378-381.
5. Duval JM, Budsberg SC. Cortical bone concentrations of enrofloxacin in dogs. Am J Vet Res 1995;56;188-192.
6. Moore RM, Schneider RK, Kowalski J, et al. Antimicrobial susceptibility of bacterial isolates from 233 horses with musculoskeletal infection during 1979-1989. Equine Vet J 1992;24: 450-456.
7. Hawkins JF, Bowman KF, Roberts MC, et al. Peritonitis in horses: 67 cases (1985-1990). J Am Vet Med Assoc 1993;203: 284-288.
8. Sweeney CR, Holcombe SJ, Barningham SC, et al. Aerobic and anaerobic bacterial isolates from horses with pneumonia or pleuropneumonia and antimicrobial susceptibility patterns of the aerobes. J Am Vet Med Assoc 1991;198:839-842.
9. Johnston JK, Divers TJ, Reef VB, et al. Cholelithiasis in horses: ten cases (1982-1986). J Am Vet Med Assoc 1989;194: 405-409.
10. Asbury AC, Lyle SK. Infectious causes of infertility. In: McKinnon AO, Voss JL, eds. Equine reproduction. Philadelphia: Lea & Febiger, 1993;381-391.
11. Burkhardt JE, Hill MA, Turek JJ, et al. Ultrastructural changes in articular cartilage of immature Beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol 1992;29:230-238.
12. Burkhardt JE, Hill MA, Carlton WW, et al. Histologic and histochemical changes in articular cartilage of immature Beagle dogs dosed with difloxacin. Toxicol Pathol 1990;27:162-170.
13. Burkhardt JE, Hill MA, Carlton WW. Morphologic and biochemical changes in articular cartilage of immature Beagle dogs dosed with difloxacin. Toxicol Pathol 1992;20:246-252.
14. Gough AW, Olajide BK, Sigler RE, et al. Quinolone arthropathy - acute toxicity to immature articular cartilage. Toxicol Pathol 1992;20:436-449.
15. Berg JN. Clinical indications for enrofloxacin in domestic animals and poultry, in Proceedings. West Vet Conf 1988;25-33.
16. Beluche LA, Bertone AL, Anderson DE, et al. In vitro dose-dependent effects of enrofloxacin on equine articular cartilage. Am J Vet Res 1999,60:577-582.
17. Gillis C, Sharkey N, Stover SM, et al. Ultrasonography as a method to determine tendon cross-sectional area. Am J Vet Res 1995,56:1270-1274.
18. McIlwraith CW. Diagnostic and surgical arthroscopy of the carpal joints. In: Diagnostic and surgical arthroscopy in the horse. 2nd ed. Philadelphia: Lea & Febiger, 1990;34-39.
19. McIlwraith CW, Foerner JJ. Diagnostic and surgical arthroscopy of the tarsocrural joint. In: Diagnostic and surgical arthroscopy in the horse. 2nd ed. Philadelphia: Lea & Febiger, 1990;7:162-167.
20. Orsini JA, Perkons S. The fluoroquinolones: clinical applications in veterinary medicine. Compend Contin Educ Pract Vet 1992;14:1491-1496.
21. Greene CE, Budsberg SC. Quinolone antimicrobial agents. 2nd ed. Washington, DC: American Society for Microbiology, 1993;473-488.
22. Hildebrand H, Kempka G, Schluter G, et al. Chondrotoxicity of quinolunes in vivo and in vitro. Arch Toxicol 1993;67:411-415.
23. Stahlman R, Forster C, Shakibaei M, et al. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother 1995;39:2013-2018.
24. Takada S, Kato M, Takayama S. Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles. J Toxicol Environ Health 1994;42:73-88.
25. Wilton LV, Pearce GL, Mann RD. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol 1996;41:277-284.
26. Domagala JM. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994;33:685-706.
27. Christ W. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother 1990;26(suppl B):219-225.
28. Vancutsem PM, Schwark WS. Effects of fluoroquinolone antimicrobials alone and in conjunction with theophylline on seizures in amygdaloid kindled rats. Mechanistic and pharmacokinetic study. Epilepsy Res 1992;13:59-71.
29. Royer RJ. Adverse drug reactions with fluoroquinolones. Therapie 1996;51:414-416.
30. Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999;28:352-364.
31. Shlosberg A, Ershov E, Bellaiche M, et al. The inhibitory effects of the fluoroquinolone antimicrobials norfloxacin and enrofloxacin on hepatic microsomal cytochrome P-450 monooxygenases in broiler chickens. Drug Metabol Drug Interact 1997;14:109-122.
32. Vancutsem PM, Babish JG. In vitro and in vivo study of the effects of enrofloxacin on hepatic cytochrome P-450. Potential for drug interactions. Vet Hum Toxicol 1996;38:254-259.
33. Van der Linden PD, van de Lei J, Nab HW, et al. Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol 1999;48:433-437.
34. Lewis JR, Gums JG, Dickensheets DL. Levofloxacin-induced bilateral Achilles tendonitis. Ann Pharmacother 1999;33:792-795.
35. Petersen W, Laprell H. Insidious rupture of the Achilles tendon after ciprofloxacin-induced tendopathy. A case report. Unfallchirurgie 1998;101:731-734.
36. Gabutti L, Stoller R, Marti HP. Fluoroquinolones as etiology of tendinopathy. Ther Umsch 1998;55:558-561.
37. Kashida Y, Kato M. Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds. Antimicrob Agents Chemother 1997;41:2389-2393.
38. Zabraniecki L, Negrier I, Vergne P, et al. Fluoroquinolone induced tendinopathy: report of 6 cases. J Rheumatol 1996;23 516-520.
39. Gillet P, Blum A, Hestin D, et al. Magnetic resonance imaging may be an asset to diagnose and classify fluoroquinolone-associated Achilles tendinitis. Fundam Clin Pharmacol 1995;9:52-56.
40. Bernard-Beaubois K, Hecquet C, Hayem G, et al. In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell Biol Toxicol 1998;14:283-292.
41. Brand HS, VanKampen GP, Van Der Korst JK. Effect of nalidixic acid, pipedimic acid, and cinoxacin on chondrocyte metabolism in explants of articular cartilage. Clin Exp Rheumatol 1990;8:393-395.
42. Giguere S, Sweeney RW, Habecker PL, et al. Tolerability of orally administered enrofloxacin in adult horses: a pilot study. J Vet Pharmacol Ther 1999;22:343-347.